Advertisement

Springer Nature is making SARS-CoV-2 and COVID-19 research free. View research | View latest news | Sign up for updates

Combined gonadotropin releasing hormone agonist/human menopausal gonadotropin therapy (GnRH-a/hMG) in normal, high, and poor responders to hMG

Abstract

Patients who failed to conceive after gonadotropin stimulation in in vitro fertilization treatment were classified into normal, high, or poor responders. They were routinely offered another cycle with a combination of a gonadotropin releasing hormone agonist and gonadotropin therapy (in order to evaluate whether this combined therapy could improve their response). The gonadotropin-induced cycle was compared with the combined therapy cycle. With the combination treatment, in the normal responders the phase of ovarian stimulation was significantly (P<0.001) prolonged, and the number of follicles and oocytes collected (5.7±0.7 vs 3.1±0.4) was increased, without any change in serum estradiol level compared to the control cycle. In high responders the number of oocytes was not modified by the combined treatment compared with the control cycle. However, serum estradiol level was significantly (P<0.005) decreased. The combined therapy did not modify any parameter of response in poor responders. We conclude that the response to combined agonist/gonadotropin therapy is dependent on the patient's own basal response. No improvement in response was expected in poor responders.

This is a preview of subscription content, log in to check access.

References

  1. 1.

    Jones HW, Acosta Jr AA, Andrews MC, Garcia JE, Jones GS, Mayer J, McDowell JS, Rosenwaks Z, Sandow BA, Veek LL, Wilkes CA: Three years of in vitro fertilization at Norfolk. Fertil Steril 1984;42:826

  2. 2.

    Muasher SJ: Stimulation protocols for patients with “atypical response.” In vitro fertilization and other assisted reproduction. NY Acad Sci 1988;541:82–95

  3. 3.

    Garcia JE, Jones GS, Acosta AA, Wright G Jr: Human menopausal gonadotropin follicular maturation for oocyte aspiration: Phase II 1981. Fertil Steril 1983;39:174–179

  4. 4.

    Mashiach S, Dor J, Goldenberg M, Shalev J, Blankstein J, Rudak E, Shoam Z, Finelt Z, Nebel L, Goldman B, Ben-Rafael Z: Protocols for induction of ovulation. NY Acad Sci 1988;541:37–45

  5. 5.

    Fleming R, Haxton MJ, Hamilton MPR, McCune GS, Black WP, MacNaughton MC, Coutts JRT: Successful treatment of infertile women with oligomenorrhea using a combination of LHRH agonist and exogenous gonadotropin. Br J Obstet Gynecol 1985;92:369–973

  6. 6.

    Fleming R, Coutts JRT: Induction of multiple follicular growth in normally menstruating women with endogenous gonadotropin suppression. Fertil Steril 1986;45:226–230

  7. 7.

    Frydman R, Furman RG, Belaisch-Allart J, Hazout A, Rainhorn JD, Fries N, Testart J: Improvements in ovarian stimulation for in vitro fertilization. In vitro fertilization and other assisted reproduction. NY Acad Sci 1988;541:30–36

  8. 8.

    De Ziegler D, Cedars MI, Randle D, Lu JKH, Judd HL, Meldrum DR: Suppression of the ovary using a gonadotropin releasing hormone agonist prior to stimulation for oocyte retrieval. Fertil Steril 1987;48:807–810

  9. 9.

    Kenigsberg D, Littman BA, Williams RF, Hodgen GD: Medical hypophysectomy. II. Variability of ovarian response to exogenous gonadotropins. Fertil Steril 1984;42:116–126

  10. 10.

    Serafini P, Stone B, Kerin J, Batzofin J, Quinn J, Marrs RD: An alternate approach to controlled ovarian hyperstimulation in “poor responses”: Pretreatment with a gonadotropin-releasing hormone analog. Fertil Steril 1988;49:90–95

  11. 11.

    Howles CM, MacNamee MC, Edwards RG: Short term use of LHRH agonist to treat poor responders entering in vitro fertilization programme. Hum Reprod 1987;2:655–656

  12. 12.

    Belaisch-Allart J, Testart J, Frydman R: Utilization of GnRH agonists for poor responders in an IVF programme. Hum Reprod 1989;4:33–34

Download references

Author information

Correspondence to Zion Ben-Rafael.

Rights and permissions

Reprints and Permissions

About this article

Cite this article

Ben-Rafael, Z., Bider, D., Dan, U. et al. Combined gonadotropin releasing hormone agonist/human menopausal gonadotropin therapy (GnRH-a/hMG) in normal, high, and poor responders to hMG. J Assist Reprod Genet 8, 33–36 (1991). https://doi.org/10.1007/BF01131588

Download citation

Key Words

  • gonadotropin releasing hormone (GnRH) analogue
  • human menopausal gonadotropin (hMG)
  • patient response